State of Alaska Department of Revenue’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.3M Sell
676,905
-29,907
-4% -$782K 0.16% 94
2026
Q1
$19.8M Buy
706,812
+9,890
+1% +$263K 0.21% 70
2025
Q4
$17.4M Sell
696,922
-33,935
-5% -$856K 0.18% 80
2025
Q3
$18.6M Sell
730,857
-40,426
-5% -$998K 0.19% 78
2025
Q2
$18.7M Sell
771,283
-25,270
-3% -$589K 0.2% 79
2025
Q1
$20.2M Buy
796,553
+17,820
+2% +$466K 0.23% 71
2024
Q4
$20.7M Sell
778,733
-57,408
-7% -$1.56M 0.23% 63
2024
Q3
$24.2M Sell
836,141
-7,500
-0.9% -$219K 0.26% 57
2024
Q2
$23.6M Sell
843,641
-18,030
-2% -$496K 0.26% 59
2024
Q1
$23.9M Sell
861,671
-33,710
-4% -$935K 0.27% 60
2023
Q4
$25.8M Sell
895,381
-56,605
-6% -$1.71M 0.31% 48
2023
Q3
$31.6M Sell
951,986
-26,400
-3% -$934K 0.4% 35
2023
Q2
$35.9M Sell
978,386
-140,711
-13% -$5.48M 0.43% 31
2023
Q1
$45.7M Sell
1,119,097
-9,542
-0.8% -$412K 0.54% 25
2022
Q4
$57.8M Buy
1,128,639
+6,845
+0.6% +$328K 0.72% 15
2022
Q3
$49.1M Sell
1,121,794
-43,171
-4% -$2.1M 0.66% 15
2022
Q2
$61.1M Buy
1,164,965
+107,476
+10% +$5.48M 0.75% 13
2022
Q1
$54.7M Sell
1,057,489
-25,964
-2% -$1.35M 0.58% 20
2021
Q4
$64M Buy
1,083,453
+28,101
+3% +$1.39M 0.62% 17
2021
Q3
$45.4M Sell
1,055,352
-16,005
-1% -$709K 0.46% 34
2021
Q2
$42M Buy
1,071,357
+23,619
+2% +$918K 0.42% 36
2021
Q1
$38M Sell
1,047,738
-43,951
-4% -$1.56M 0.41% 39
2020
Q4
$40.2M Sell
1,091,689
-122,717
-10% -$4.5M 0.46% 30
2020
Q3
$42.3M Buy
1,214,406
+23,109
+2% +$810K 0.52% 27
2020
Q2
$37M Buy
1,191,297
+89,837
+8% +$3.05M 0.47% 30
2020
Q1
$34.1M Buy
1,101,460
+57,271
+5% +$1.95M 0.54% 23
2019
Q4
$38.8M Sell
1,044,189
-146,049
-12% -$5.2M 0.51% 28
2019
Q3
$40.6M Sell
1,190,238
-251,637
-17% -$9.15M 0.55% 27
2019
Q2
$59.3M Buy
1,441,875
+11,190
+0.8% +$444K 1% 7
2019
Q1
$57.6M Sell
1,430,685
-54,045
-4% -$2.16M 1.02% 6
2018
Q4
$61.5M Sell
1,484,730
-1,937
-0.1% -$80.4K 1.19% 5
2018
Q3
$62.2M Sell
1,486,667
-82,333
-5% -$3.17M 1.05% 5
2018
Q2
$54M Buy
1,569,000
+175,539
+13% +$6M 0.96% 7
2018
Q1
$46.9M Buy
1,393,461
+88,167
+7% +$3.03M 0.98% 6
2017
Q4
$44.9M Buy
1,305,294
+539,976
+71% +$18.4M 1.07% 6
2017
Q3
$25.9M Buy
765,318
+38,903
+5% +$1.25M 1.31% 3
2017
Q2
$23.1M Buy
726,415
+219,063
+43% +$6.91M 1.58% 3
2017
Q1
$16.5M Buy
507,352
+5,838
+1% +$184K 1.2% 12
2016
Q4
$15.5M Sell
501,514
-12,366
-2% -$378K 1.48% 10
2016
Q3
$16.5M Buy
513,880
+121,911
+31% +$4.08M 1.73% 7
2016
Q2
$13.1M Buy
391,969
+39,680
+11% +$1.27M 1.36% 12
2016
Q1
$9.91M Sell
352,289
-22,598
-6% -$645K 1.03% 31
2015
Q4
$11.5M Buy
374,887
+158,511
+73% +$4.99M 1.61% 10
2015
Q3
$6.45M Buy
216,376
+42,034
+24% +$1.35M 1.41% 13
2015
Q2
$5.55M Hold
174,342
1.2% 20
2015
Q1
$5.75M Sell
174,342
-42,793
-20% -$1.36M 1.15% 21
2014
Q4
$6.42M Sell
217,135
-11,088
-5% -$318K 1.32% 17
2014
Q3
$6.4M Buy
228,223
+38,714
+20% +$1.09M 1.45% 14
2014
Q2
$5.34M Buy
189,509
+25,296
+15% +$721K 1.08% 25
2014
Q1
$5M Buy
164,213
+155,950
+1,887% +$4.65M 1.08% 25
2013
Q4
$240K Sell
8,263
-6,883
-45% -$200K 0.06% 174
2013
Q3
$412K Buy
15,146
+1,760
+13% +$47.9K 0.1% 154
2013
Q2
$355K Buy
+13,386
New +$370K 0.09% 156

Other funds holding PFE

State of Alaska Department of Revenue's PFE Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its Pfizer (PFE) stake by 4.2% in Q2 2026, selling an estimated $782K and leaving 676,905 shares worth $16.3M. The position accounts for 0.16% of the portfolio, ranked #94.

State of Alaska Department of Revenue first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $64M in Q4 2021. 2,303 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • State of Alaska Department of Revenue held 676,905 shares of Pfizer worth $16.3M as of Q2 2026.
  • State of Alaska Department of Revenue sold 29,907 Pfizer shares in Q2 2026, an estimated $782K.
  • Pfizer made up 0.16% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #94 holding.
  • State of Alaska Department of Revenue first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • State of Alaska Department of Revenue's Pfizer position peaked at $64M in Q4 2021.
  • 2,303 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.